Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Osmotic Diuresis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
20
Start Date:
April 2021
Research Project: Pilot Study on Oral Urea Use in Patients at High Risk of Kidney Stone Recurrence
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
172
Start Date:
January 2021
Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia - a Monocentric Randomized Double-blind Placebo-controlled Trial (the EMPOWER Study)
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug, Diagnostic Test
Participants:
72
Start Date:
July 1, 2020
A Single-center, Prospective, Placebo-controlled, Double-blind, Randomized, Cross-over Mechanistic Intervention Study to Investigate the Effect of Empagliflozin on Kidney Function in People With Either Preserved or Impaired Kidney Function With or Without Type 2 Diabetes
Clinical Trial
Status:
Recruiting
Phase:
Phase 4
Intervention Type:
Drug, Device
Participants:
90
Start Date:
December 1, 2019
Effect of Sodium Glucose co Transporter 2 (SGLT2) Inhibition on Optical Coherence Tomography Angiography (OCT-A) Parameters in Diabetic Chronic Kidney Disease (CKD)
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
60
Start Date:
September 29, 2019
Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure
Clinical Trial
Status:
Active, not recruiting
Phase:
N/A
Intervention Type:
Dietary Supplement, Diagnostic Test
Participants:
300
Start Date:
June 24, 2019
Food and Salt Handling in Diuresis: Research on Effects and Mechanisms of Food and Nutrients in Urine Output and Composition
Clinical Trial
Status:
Recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
20
Start Date:
February 14, 2019
Effect of Dapagliflozin on the Blood Pressure Variability and the Ambulatory Arterial Stiffness Index in Individuals With Stage I Hypertension Without Diabetes Mellitus
Clinical Trial
Status:
Recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug
Participants:
16
Start Date:
December 15, 2017
Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
Showing 1-8 of 8